Prevention

Almost one-third of adults aged 60 years and older without CVD regularly used aspirin for primary prevention in 2021, contrary to guidance from medical organizations, a study showed.

Prevention of heart disease will do more good in the long run than procedures to treat advanced heart disease, the incoming president of National Lipid Association said at the NLA’s Scientific Sessions.

The CDC has published guidance recommending that providers counsel certain patients on the harms and benefits of doxycycline for post-exposure prophylaxis — or doxy-PEP — for the prevention of sexually transmitted infections.

A nationally representative survey showed high use of evidence-based technical interventions to prevent central line-associated bloodstream infections in recent years; however, gaps remain in use of behavioral interventions.

Patients with stroke history had significantly poorer CV prevention profiles compared with patients with history of MI, with pronounced disparities based on race and neighborhood deprivation status, according to study results.

The Biden-Harris Administration released the 2024 National Strategy for Suicide Prevention and Federal Action Plan, which includes actions to address substance use and suicide risk and evaluate community-based suicide prevention efforts.

BOSTON — Aspirin may not be as beneficial vs. other agents for primary CVD prevention following recent research, according to a speaker at the ACP Internal Medicine Meeting.

The Early Allergen System Experience trial will use real-world infant health care data to assess how the early introduction of allergens via supplements will impact the development of allergies and associated health care costs.

In a three-part supplement series published in Morbidity and Mortality Weekly Report, the CDC released updated and expanded guidance for community assessment and response to suicide clusters for the first time since 1988.

The FDA approved a second pulsed field ablation system for the treatment of paroxysmal atrial fibrillation based on real-world data from the MANIFEST-17K registry and positive findings from the pivotal ADVENT clinical trial.